Showing results (131-140 of 388) with videos related to

Sort By:
Pageof 39
Chemical Biology & Drug Design|September 9, 2015
Design, Synthesis, and Biological Evaluation of Novel 2-(Pyridin-3-yloxy)acetamide Derivatives as Potential Anti-HIV-1 AgentsBoshi Huang, Xiao Li, Peng Zhan, et al.
Advances in Experimental Medicine and Biology|July 14, 2021
Search, Identification, and Design of Effective Antiviral Drugs Against Pandemic Human CoronavirusesTianguang Huang, Lin Sun, Dongwei Kang, et al.
Chemmedchem|October 12, 2010
Synthesis, in vitro and in vivo release kinetics, and anti-HIV activity of a sustained-release prodrug (mPEG-AZT) of 3'-azido-3'-deoxythymidine (AZT, Zidovudine)Wenjun Li, Yu Chang, Peng Zhan, et al.
Chemmedchem|February 16, 2011
Synthesis and biological evaluation of 6-substituted 5-alkyl-2-(phenylaminocarbonylmethylthio)pyrimidin-4(3H)-ones as potent HIV-1 NNRTIsMingyan Yu, Zhenyu Li, Shuai Liu, et al.
Bioorganic & Medicinal Chemistry|February 19, 2013
Synthesis and biological evaluation of pyridazine derivatives as novel HIV-1 NNRTIsDongyue Li, Peng Zhan, Huiqing Liu, et al.
Bioorganic & Medicinal Chemistry|October 15, 2013
Design, synthesis and biological evaluation of N2,N4-disubstituted-1,1,3-trioxo-2H,4H-pyrrolo[1,2-b][1,2,4,6]thiatriazine derivatives as HIV-1 NNRTIsWenmin Chen, Peng Zhan, Erik De Clercq, et al.
Bioorganic & Medicinal Chemistry|August 1, 2009
Synthesis and biological evaluation of imidazole thioacetanilides as novel non-nucleoside HIV-1 reverse transcriptase inhibitorsPeng Zhan, Xinyong Liu, Junjie Zhu, et al.
Chemical Biology & Drug Design|July 15, 2011
Discovery of dihydro-alkyloxy-benzyl-oxopyrimidines as promising anti-influenza virus agentsMingyan Yu, Ailin Liu, Guanhua Du, et al.
Expert Opinion on Therapeutic Patents|August 5, 2020
Discovery and optimizing polycyclic pyridone compounds as anti-HBV agentsFenju Wei, Dongwei Kang, Srinivasulu Cherukupalli, et al.
Drug Discovery Today|July 1, 2024
Recent advances in the molecular design and applications of viral RNA-targeting antiviral modalitiesJiaojiao Dai, Xiangyi Jiang, Edeildo Ferreira da Silva-Júnior, et al.
Pageof 39